Florian Arndt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Florian Arndt has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Dulcey
Department of Pediatrics, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland, unibe.ch
1 shared publication - Andrea Duppenthaler
Division of Pediatric Infectious Disease, Department of Pediatrics, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland, unibe.ch
1 shared publication - Christoph Aebi
Division of Paediatric Infectious Diseases, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
1 shared publication - Emilija Zimnickaite
Department of Pediatrics, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland, unibe.ch
1 shared publication Fabienne Stoller
Department of Cardiology, Center for Congenital Heart Disease, Inselspital, University Hospital of Bern, University of Bern, Bern, Switzerland, unibe.ch
1 shared publication- Nina Schöbi
Inselspital, Bern University Hospital, University of Bern
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2026 (1)
Management of Coxiella burnetii Endocarditis in a Child With Congenital Heart Disease
A 6‐year‐old male patient with pulmonary atresia and recent valve replacement with a Melody valve presented with a 6‐week history of fever and cough. He was diagnosed with Coxiella burnetii endocarditis based on a C. burnetii Phase I IgG antibody titre of 1:65,536 and increased metabolic activity surrounding his prosthetic cardiac valve on positron emission tomography scan. Treatment was initiated with doxycycline and hydroxychloroquine. However, despite dose escalation, target plasma concentrations were not achieved. The patient experienced rapid clinical improvement, and serological markers declined gradually. Antimicrobial therapy was discontinued after 40 months, as predefined serological criteria were met, clinical course was favourable, and a follow‐up positron emission tomography scan demonstrated a significant reduction in metabolic activity around the prosthetic valve. Up to 23 months after cessation of therapy, the patient showed no evidence of active C. burnetii endocarditis during follow‐up. The Melody valve maintained its function, and valve replacement was not required. Clinicians should employ an individualised treatment approach to children with C. burnetii endocarditis.
- 1 January 2026
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2026 (1)
Open AccessManagement of Coxiella burnetii Endocarditis in a Child With Congenital Heart Disease
A 6‐year‐old male patient with pulmonary atresia and recent valve replacement with a Melody valve presented with a 6‐week history of fever and cough. He was diagnosed with Coxiella burnetii endocarditis based on a C. burnetii Phase I IgG antibody titre of 1:65,536 and increased metabolic activity surrounding his prosthetic cardiac valve on positron emission tomography scan. Treatment was initiated with doxycycline and hydroxychloroquine. However, despite dose escalation, target plasma concentrations were not achieved. The patient experienced rapid clinical improvement, and serological markers declined gradually. Antimicrobial therapy was discontinued after 40 months, as predefined serological criteria were met, clinical course was favourable, and a follow‐up positron emission tomography scan demonstrated a significant reduction in metabolic activity around the prosthetic valve. Up to 23 months after cessation of therapy, the patient showed no evidence of active C. burnetii endocarditis during follow‐up. The Melody valve maintained its function, and valve replacement was not required. Clinicians should employ an individualised treatment approach to children with C. burnetii endocarditis.